Software takes aim at reducing pediatric ADHD symptoms

Researchers have developed new software that helps children diagnosed with ADHD minimize symptoms when receiving care at community pediatric practices. Combining medication and care, patients are able to reduce symptoms by 13 points on Vanderbilt parent-rated scale of symptoms.

The new software was developed by researchers led by Jeffery Epstein, PhD, director of the Center for ADHD at Cincinnati Children's Hospital Medical Center. Collecting, scoring and interpreting reports on the patient, the software rates the severity of symptoms and decides if medications are needed. Based on these calculations, the community care provider makes a personalized schedule and receives information about the patient's reaction.

"Our data show the software not only helped improve the quality of medication care received by children treated at community based pediatric practices, but it also improved treatment outcomes for these children," Epstein said. "As a result of the improved quality of ADHD care, children treated by pediatricians using this new technology had significantly less ADHD symptoms than children treated by pediatricians who were not given access to this web-based technology."

A clinical trial was conducted 50 community based pediatric practices on 373 children with ADHD who were prescribed medication (165 were provided the software while 208 were not). Results showed that children without the software experienced a 10.19-point reduction of symptoms, in regards to the Vanderbilt ADHD Parent Rating Scale. Children with both medication and the software averaged a 13.19-point reduction.  

Epstein hopes that the software could be extended to offer behavior treatment to all patients with ADHD and other pediatric mental disorders.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”